» Articles » PMID: 7381003

Lactose-positive Vibrio in Seawater: a Cause of Pneumonia and Septicemia in a Drowning Victim

Overview
Specialty Microbiology
Date 1980 Mar 1
PMID 7381003
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Lactose-positive Vibrio is a recently recognized marine organism that has pathogenic potential for humans. An organism was isolated from the sputum and blood of a man who was resuscitated after drowning in the sea. The isolates from both sources had the characteristics of lactose-positive Vibrio, which include positive oxidase, citrate, indole, and o-nitrophenyl-beta-D-galactopyranoside reactions and negative Voges-Proskauer, urease, and sucrose reactions. Seawater samples from 21 sites around Galveston Island were cultured for lactose-positive Vibrio over a period of 4 weeks, and 36% of the samples yielded the organism. The environmental isolates were very similar to the clinical isolates in biochemical reactions and susceptibility to antimicrobial agents. The results indicate that lactose-positive Vibrio is a common organism in the marine environment and that it should be considered in the diagnosis of infections, including pneumonia, associated with exposure to the sea.

Citing Articles

Vibrio vulnificus pneumonia with multiorgan failure: a case report and review of the literature.

Abeyagunawardena I, Priyankara D J Med Case Rep. 2023; 17(1):205.

PMID: 37202814 PMC: 10195120. DOI: 10.1186/s13256-023-03943-9.


Seawater drowning-associated pneumonia: a 10-year descriptive cohort in intensive care unit.

Robert A, Danin P, Quintard H, Degand N, Martis N, Doyen D Ann Intensive Care. 2017; 7(1):45.

PMID: 28447330 PMC: 5406314. DOI: 10.1186/s13613-017-0267-4.


Antibacterial activity of biosecur(®) citrus extract surface cleaner against Vibrio vulnificus.

Cormier J, Scott R, Janes M Open Microbiol J. 2013; 7:130-4.

PMID: 24302976 PMC: 3845258. DOI: 10.2174/1874285801307010130.


In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.

Kim D, Lym Y, Jang S, Han H, Kim Y, Chung C Antimicrob Agents Chemother. 2005; 49(8):3489-91.

PMID: 16048966 PMC: 1196224. DOI: 10.1128/AAC.49.8.3489-3491.2005.


In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.

Tang H, Chang M, Ko W, Huang K, Lee C, Chuang Y Antimicrob Agents Chemother. 2002; 46(11):3580-4.

PMID: 12384368 PMC: 128723. DOI: 10.1128/AAC.46.11.3580-3584.2002.


References
1.
BAUER A, KIRBY W, SHERRIS J, Turck M . Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4):493-6. View

2.
ROLAND F . Leg gangrene and endotoxin shock due to vibrio parahaemolyticus--an infection acquired in New England coastal waters. N Engl J Med. 1970; 282(23):1306. DOI: 10.1056/NEJM197006042822306. View

3.
Barker Jr W . Vibrio parahaemolyticus outbreaks in the United States. Lancet. 1974; 1(7857):551-4. DOI: 10.1016/s0140-6736(74)92727-5. View

4.
Hollis D, Weaver R, Baker C, Thornsberry C . Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol. 1976; 3(4):425-31. PMC: 274318. DOI: 10.1128/jcm.3.4.425-431.1976. View

5.
Blake P, Merson M, Weaver R, Hollis D, Heublein P . Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979; 300(1):1-5. DOI: 10.1056/NEJM197901043000101. View